CRIS Current Research Information System

SERRETTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.568
AS - Asia 26.203
EU - Europa 21.210
SA - Sud America 2.183
AF - Africa 1.520
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 21
Totale 85.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.261
SG - Singapore 7.054
CN - Cina 6.690
VN - Vietnam 6.628
GB - Regno Unito 5.512
DE - Germania 3.588
IT - Italia 3.177
FR - Francia 2.067
HK - Hong Kong 1.983
SE - Svezia 1.925
BR - Brasile 1.630
IN - India 1.361
RU - Federazione Russa 1.322
UA - Ucraina 1.181
IE - Irlanda 717
KR - Corea 582
JP - Giappone 565
ZA - Sudafrica 521
EE - Estonia 407
CI - Costa d'Avorio 329
NL - Olanda 320
SC - Seychelles 299
AR - Argentina 244
JO - Giordania 224
TG - Togo 183
FI - Finlandia 156
AT - Austria 154
ID - Indonesia 153
CA - Canada 137
BD - Bangladesh 125
MX - Messico 116
BG - Bulgaria 107
IQ - Iraq 107
PH - Filippine 103
CH - Svizzera 98
EC - Ecuador 92
AU - Australia 91
TR - Turchia 88
PL - Polonia 82
PK - Pakistan 78
TH - Thailandia 76
BE - Belgio 74
ES - Italia 67
GR - Grecia 63
CO - Colombia 61
CL - Cile 48
UZ - Uzbekistan 46
SA - Arabia Saudita 45
LB - Libano 40
PY - Paraguay 38
TW - Taiwan 34
IL - Israele 32
MA - Marocco 29
MY - Malesia 29
VE - Venezuela 29
TN - Tunisia 28
EG - Egitto 26
CZ - Repubblica Ceca 24
NP - Nepal 24
IR - Iran 23
KE - Kenya 23
LT - Lituania 22
PE - Perù 22
RO - Romania 20
AE - Emirati Arabi Uniti 18
DZ - Algeria 17
DK - Danimarca 15
AZ - Azerbaigian 14
EU - Europa 14
RS - Serbia 14
HU - Ungheria 13
JM - Giamaica 13
AL - Albania 12
ET - Etiopia 12
NO - Norvegia 12
NZ - Nuova Zelanda 12
KZ - Kazakistan 11
PA - Panama 11
UY - Uruguay 11
GE - Georgia 10
HR - Croazia 10
NG - Nigeria 10
PS - Palestinian Territory 10
PT - Portogallo 9
SK - Slovacchia (Repubblica Slovacca) 9
DO - Repubblica Dominicana 8
GH - Ghana 6
KW - Kuwait 6
LV - Lettonia 6
MT - Malta 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
BW - Botswana 5
KG - Kirghizistan 5
MU - Mauritius 5
OM - Oman 5
SN - Senegal 5
SV - El Salvador 5
AM - Armenia 4
Totale 85.720
Salva come PNG Salva come JPEG
Città #
Southend 4.806
Singapore 4.510
Fairfield 4.502
Ashburn 3.050
Cambridge 2.283
Woodbridge 2.109
Seattle 1.960
Wilmington 1.879
Hong Kong 1.878
San Jose 1.828
Houston 1.817
Santa Clara 1.756
Ho Chi Minh City 1.513
Chandler 1.259
Ann Arbor 1.256
Hanoi 1.230
Princeton 1.222
Hefei 1.214
Dong Ket 1.065
Boardman 778
Lauterbourg 748
Jacksonville 734
Dublin 710
Beijing 635
Seoul 541
Westminster 510
Frankfurt am Main 486
Tokyo 476
Padova 469
Nanjing 466
Los Angeles 430
Bologna 397
Berlin 357
Dallas 343
Abidjan 329
Buffalo 286
San Diego 275
Saint Petersburg 271
Shenyang 225
Amman 220
Jinan 220
Milan 214
Redondo Beach 199
Lomé 183
Mülheim 183
Turin 183
Council Bluffs 175
Haiphong 175
Da Nang 168
Hebei 166
Changsha 163
Nanchang 163
New York 154
Guangzhou 149
Rome 148
São Paulo 142
Shanghai 132
Chicago 131
Des Moines 126
Bengaluru 122
Burlington 122
Tianjin 119
Helsinki 105
Jiaxing 102
Dearborn 100
Sofia 99
Vienna 93
The Dalles 90
Zhengzhou 90
Nuremberg 89
London 87
Hangzhou 84
Mahé 81
Jakarta 80
Grafing 78
Biên Hòa 77
Hải Dương 71
Falls Church 68
Norwalk 67
Yubileyny 65
Haikou 64
Olalla 64
Quận Bình Thạnh 64
Ha Long 63
Verona 62
Phoenix 60
Orem 59
Thái Nguyên 58
Bern 56
Brussels 56
Ningbo 56
Ninh Bình 55
Paris 55
Can Tho 54
Rio de Janeiro 54
Warsaw 53
Redwood City 50
Kunming 48
Naples 48
Fuzhou 46
Totale 57.011
Salva come PNG Salva come JPEG
Nome #
Il suicidio assistito per pazienti con depressione grave. Un’opzione inaccettabile che gli psichiatri devono combattere fermamente 806
5-HTTLPR and gender differences in affective disorders: A systematic review 685
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 442
A molecular pathway analysis informs the genetic background at risk for schizophrenia 389
Lithium exposure during pregnancy and the postpartum period: A systematic review and meta-analysis of safety and efficacy outcomes 387
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 351
A genetic dissection of antipsychotic induced movement disorders. 340
The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. 315
L'UTILITA' DELLE MEDITAZIONI BASATE SULLA CONSAPEVOLEZZA PER I DISTURBI PSICHIATRICI: UNA REVIEW SISTEMATICA 282
Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: Systematic review and indirect treatment comparison 275
A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders. 260
Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes 250
Psychometric characteristic of the Italian version of the Temperament and Character Inventory-Revised (TCI-R). Personality, psychopathology and attachment styles 249
The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis 239
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression 227
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 223
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 220
Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient with Chronic Renal Failure: A Case Report 219
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. 218
Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. 217
Social brain, social dysfunction and social withdrawal 217
Metabolic risk factor profile associated with use of second generation antipsychotics: a cross-sectional study in a community mental health centre 216
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries 216
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. 216
The 5-HT2C receptor as a target for mood disorders. 215
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 214
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. 210
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 208
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) trial 208
COMT and age at onset in mood disorders: a replication and extension study. 207
A molecular pathway analysis of the glutamatergic–monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment 206
How do genes exert their role? Period 3 gene variants and possible influences on mood disorder phenotypes 203
New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others 202
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder 201
Patterns of antipsychotic prescription and accelerometer-based physical activity levels in people with schizophrenia spectrum disorders: a multicenter, prospective study 200
Catechol-o-methyltransferase gene modulation on suicidal behavior and personality traits: review, meta-analysis and association study. 200
Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. 199
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder 198
Antidepressants and body weight: a comprehensive review and meta-analysis 198
3111T/C clock gene polymorphism is not associated with sleep disturbances in untreated depressed patients 197
A model to investigate SNPs' interaction in GWAS studies 196
The role of specific early trauma in adult depression: A meta-analysis of published literature. Childhood trauma and adult depression 196
A targeted use of DNA microarrays in the pharmacogenetics of antidepressants: pros and cons 194
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 192
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. 192
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study 192
Collaborative meta-Analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression 191
Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways 190
5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies 190
Monocyte chemoattractant protein-1 promoter -2518 polymorphism and schizophrenia in the Korean population. 189
A neural network model for combining clinical predictors of antidepressant response in mood disorders 189
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients 189
A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. 189
Benefit of slow titration of paroxetine to treat depression in the elderly 189
Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. 188
5-HT(2A) SNPs and the Temperament and Character Inventory 187
DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients 187
A protective genetic variant for adverse environments? The role of childhood traumas and serotonin transporter gene on resilience and depressive severity in a high-risk population 186
Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder. 185
5-HT(1A) polymorphism and self-transcendence in mood disorders 184
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 183
Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders 182
Antidepressants in healthy subjects: what are the psychotropic/psychological effects? 182
Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorder 182
Low comorbid obsessive-compulsive disorder in patients with major depressive disorder – Findings from a European multicenter study 182
Clinical factors related to schizophrenia relapse 181
null 181
Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials. 181
Role of Substance Abuse Comorbidity and Personality on the Outcome of Depression in Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome 180
The microtubule-associated molecular pathways may be genetically disrupted in patients with Bipolar Disorder. Insights from the molecular cascades 180
Association between Sirtuin 2 gene rs10410544 polymorphism and depression in Alzheimer's disease in two independent European samples. 179
Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: One-month prospective evaluation. 179
Adenosine Hypothesis of Antipsychotic Drugs Revisited: Pharmacogenomics Variation in Nonacute Schizophrenia 179
Correlation of a set of gene variants, life events and personality features on adult ADHD severity 178
A systematic review of neurobiological and clinical features of mindfulness meditations 178
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 178
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - A European multicentre study 178
Progress and prospects in pharmacogenetics of antidepressant drugs 178
Maoa and Maob polymorphisms and personality traits in suicide attempters and healthy controls: a preliminary study 178
Lack of Association between Interleukin-1 alpha rs1800587 Polymorphism and Alzheimer's Disease in Two Independent European Samples 178
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders 177
TAAR6 variations possibly associated with antidepressant response and suicidal behavior 177
The association between electrodermal activity (EDA), depression and suicidal behaviour: A systematic review and narrative synthesis 177
Association between COMT (Val(158)Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study 176
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes 176
Cognitive markers of psychotic unipolar depression: A meta-analytic study 176
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls 176
Genome-wide association study identifies 30 loci associated with bipolar disorder 175
Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder 175
TAAR 6 and HSP-70 variations associated with bipolar disorder 174
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders 173
Association between the estrogen receptor TA polymorphism and Harm avoidance 173
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 173
APOE epsilon-4 allele and cytokine production in Alzheimer's disease 172
Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study 172
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression. 172
Alexithymia: phisiopathology, etiology and management 171
Weight gain in antipsychotic-naive patients: a review and meta-analysis 171
Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder 170
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. 170
Totale 21.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 231.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 231.750
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.847 0 0 0 0 0 0 0 0 0 422 348 2.077
2021/20229.193 922 346 678 569 879 569 272 794 311 909 1.658 1.286
2022/20238.083 927 1.151 477 840 509 506 328 456 1.449 242 792 406
2023/20242.414 155 408 196 210 190 373 180 201 106 204 86 105
2024/202511.880 277 1.949 855 815 2.512 695 743 300 213 563 613 2.345
2025/202626.508 2.651 3.030 3.019 2.486 2.716 1.771 2.764 2.669 4.001 1.401 0 0
Totale 87.057